Prescription drug · BLA
Humalog (insulin lispro) NDC 50090-4488
Insulin lispro 100 [iU]/mL · Injection, Solution · Intravenous, Subcutaneous · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-4488-0 | 50090448800 | 1 VIAL in 1 CARTON (50090-4488-0) / 10 mL in 1 VIALMarketed from Aug 29, 2019 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Humalog
- Generic name (nonproprietary)
- insulin lispro
- Active ingredients
- Insulin lispro — 100 [iU]/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous, Subcutaneous
- Labeler
- A-S Medication Solutions
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 020563
- Marketing start
- Listing expires
- Other FDA classes
- Insulin (Chemical/Ingredient)
- Identifiers
- Product ID 50090-4488_53d23f9f-69bb-43bb-9d90-0f8a89b68ae7SPL ID 53d23f9f-69bb-43bb-9d90-0f8a89b68ae7SPL set ID 6ee01d2e-3525-4aa9-8ec1-5fb0f63dd47cRxCUI 242120, 865098UNII GFX7QIS1II
- Pharmacologic class
- Insulin Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N450090448800followed by a unit qualifier and the quantityPackage 50090-4488-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
HUMALOG is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. HUMALOG is a rapid acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under BLA 020563
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Insulin Lispro | Insulin lispro 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | A-S Medication Solutions | 50090-5391 |
| Humalog KwikPeninsulin lispro | Insulin lispro 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Eli Lilly and Company | 0002-8799 |
| Sterile Diluentdiluent | Water 1 mL/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-0800 |
| Humaloginsulin lispro | Insulin lispro 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Eli Lilly and Company | 0002-7516 |
| Insulin Lispro Junior KwikPeninsulin lispro | Insulin lispro 100 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-7752 |
| Humaloginsulin lispro | Insulin lispro 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Eli Lilly and Company | 0002-7510 |
| Humalog Junior KwikPeninsulin lispro | Insulin lispro 100 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-7714 |
| Insulin Lispro KwikPeninsulin lispro | Insulin lispro 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Eli Lilly and Company | 0002-8222 |
| Humaloginsulin lispro | Insulin lispro 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | A-S Medication Solutions | 50090-1375 |
| Humalog KwikPeninsulin lispro | Insulin lispro 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | A-S Medication Solutions | 50090-4073 |
| Insulin Lispro | Insulin lispro 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Eli Lilly and Company | 0002-7737 |
| Humalog KwikPeninsulin lispro | Insulin lispro 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | A-S Medication Solutions | 50090-1663 |
| Humalog Tempo Peninsulin lispro | Insulin lispro 100 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-8213 |
- openFDA data updated
Med-Code stores this record for up to 24 hours before requesting it again.
Reference information only. Verify codes and billing rules against the applicable payer and official source before submitting a claim. How Med-Code handles data.